Juvenilna gigantomastija: supkutana mastektomija sa primarnom rekonstrukcijom
Sažetak
Uvod. Gigantomastija predstavlja jednu od najozbiljnijih anomalija ženskih dojki, a nastaje usled njihovog patološkog uvećanja. Juvenilna gigantomastija (JG) dojki je retka bolest, nepoznate etiologije, koju karakteriše nagli i alarmantno brzi, kontinuirani rast dojki u pubertetskom periodu. Prikaz bolesnika. Prikazujemo dve bolesnice sa masivnom bilateralnom JG. Obe bolesnice imale su normalan hormonski status i negirale bilo kakve druge zdravstvene probleme, uključujući porodičnu istoriju gigantomastije. Koža grudi obe bolesnice bila je crvena, bez ulceracija, sa vidno uvećanim površnim venama. Bradavice nisu bile jasno definisane u odnosu na okolnu kožu i bile su postavljene ispod nivoa pupka. Bolesnice su uspešno lečene hirurškom tehnikom koja je uključivala bilateralnu supkutanu mastektomiju sa primarnom rekonstrukcijom dojki poliuretanskim implantatima kao i rekonstrukciju bradavice tehnikom slobodnog grafa. U histopatološkim nalazima iz uzoraka biopsije obe bolesnice nađena je difuzna hiperplazija žlezdanog i stromalnog tkiva. Obe bolesnice imale su odlične estetske rezultate sa minimalno vidiljvim postoperativnim ožiljcima. Zaključak. Hirurško lečenje je primarno sredstvo u lečenju JG. Prikazani su značajni rezultati i efekti plastične hirurgije, a primenjeni hirurški metod može se preporučiti za uspešno lečenje JG.
Reference
1. Dieffenbach JF. Die extirpation der bruestdruese. In: Dieffenbach JF, editor. Die Operative Chirurgie. Leipzig: Brockhaus; 1848. p. 359‒73. (German)
2. Wolfswinkel EM, Lemaine V, Weathers WM, Chike-Obi CJ, Xue AS, Heller L. Hyperplastic breast anomalies in the female adolescent breast. Semin Plast Surg 2013; 27(1): 49–55.
3. Zargar AH, Laway BA, Masoodi SR, Chowdri NA, Wani AI. Unilateral gestational macromastia-an unusual presentation of a rare disorder. Postgrad Med J 1999; 75(880): 101‒3.
4. Kupfer D, Dingman D, Broadbent R. Juvenile breast hypertophy: Report of a familial pattern and review of the literature. Plast Reconstr Surg 1992; 90(2): 303‒9.
5. Govrin-Yehudain J, Kogan L, Cohen HI, Falik-Zaccai TC. Familial juvenile hypertrophy of the breast. J Adolesc Health 2004; 35(2): 151‒5.
6. Netscher DT, Mosharrafa AM, Laucirica R. Massive asymmetric virginal breast hypertrophy. South Med J 1996; 89(4): 434‒7.
7. Dafydd H, Roehl KR, Phillips LG, Dancey A, Peart F, Shokrollahi K. Redefining gigantomastia. J Plast Reconstr Aesthet Surg 2011; 64(2): 160‒3.
8. Kulkarni D, Beechey-Newman N, Hamed H, Fentiman IS. Gigantomastia: A problem of local recurrence. Breast 2006; 15(1): 100‒2.
9. Durston W. An extract of a letter written to the publisher from Plymouth Novem. 2. 1669. by William Durston Dr. of Physick; concerning the death of the big-breasted woman (discoursed of in numb. 52.) together with what was thereupon observed in her body. Royal Soc (London) 1669; 4(45‒56): 1068‒9.
10. Zhong A, Wang G, Yang J, Xu Q, Yuan Q, Yang Y, et al. Stromal-epithelial cell interactions and alteration of branching morphogenesis in macromastic mammary glands. J Cell Mol Med 2014; 18(7): 1257‒66.
11. Pülzl P, Schoeller T, Tzankov A, Wechselberger G. Unilateral breast enlargement 5 years after reduction mammaplasty. Aesthetic Plast Surg 2005; 29(5): 404‒6.
12. Wechselberger G, Pülzl P, Pichler M, Schoeller T, Piza-Katzer H. Juvenile gigantomastia treated by reduction mammoplasty. Am J Surg 2004; 188(3): 333‒4.
13. Arscott GD, Craig HR, Gabay L. Failure of bromocriptine therapy to control juvenile mammary hypertrophy. Br J Plast Surg 2001; 54(8): 720‒3.
14. Touraine P, Youssef N, Alyanakian MA, Lechat X, Balleyguier C, Duflos C, et al. Breast inflammatory gigantomastia in a context of immune-mediated diseases. J Clin Endocrinol Metab 2005; 90(9): 5287‒94.
15. Duffy DA, Demers ML, Molin MR. Systemic lupus erythematosus with breast gigantism. J Rheumatol 1995; 22: 1214‒5.
16. Li G, Robinson GW, Lesche R, Martinez-Diaz H, Jiang Z, Rozengurt N, et al. Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 2002; 129(17): 4159–70.
17. Koves IH, Zacharin M. Virginal breast hypertrophy of an 11-year-old girl. Journal of paediatrics and child health 2007; 43(4): 315–7.
18. Fusco N, Sajjadi E, Venetis K, Gaudioso G, Lopez G, Corti C, et al. PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine? Genes (Basel) 2020; 11(7): 719.
19. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987; 317(17): 1098.
20. Güneş D, Mutafoğlu-Uysal K, Canda T, Saydam S, Cemeroğlu AP, Olgun N. Unilateral juvenile (virginal) hypertrophy of the breast. Turk J Pediatr 2008; 50(3): 278‒81.
21. Hoppe IC, Patel PP, Singer-Granick CJ, Granick MS. Virginal mammary hypertrophy: a meta-analysis and treatment algorithm. Plast Reconstr Surg 2011; 127(6): 2224‒31.
22. Fiumara L, Gault DT, Nel MR, Lucas DN, Courtauld E. Massive bilateral breast reduction in an 11-year-old girl: 24% ablation of body weight. J Plast Reconstr Aesthet Surg 2009; 62(8): e263‒6.
23. Hisham A, Abd Latib M, Basiron N. Juvenile Breast Hypertrophy: A Successful Breast Reduction of 14.9% Body Weight without Recurrence in a 5-Year Follow-Up. Case Rep Surg 2017; 2017: 3491012.
24. Qin F, Si L, Zhang H, Zhang M, Zeng A, Long F, et al. Management of gestational gigantomastia with breast reconstruction after mastectomy: case report and literature review. J Int Med Res 2020; 48(6): 300060520920463.
25. Pruthi S, Jones KN. Nonsurgical management of fibroadenoma and virginal breast hypertrophy. Semin Plast Surg 2013; 27(1): 62‒6.
26. Barton MB, West CN, Liu IL, Harris EL, Rolnick SJ, Elmore JG, et al. Complications following bilateral prophylactic mastectomy. J Natl Cancer Inst Monogr 2005; (35): 61‒6.